Your browser doesn't support javascript.
loading
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques.
Marlin, Romain; Godot, Veronique; Cardinaud, Sylvain; Galhaut, Mathilde; Coleon, Severin; Zurawski, Sandra; Dereuddre-Bosquet, Nathalie; Cavarelli, Mariangela; Gallouët, Anne-Sophie; Maisonnasse, Pauline; Dupaty, Léa; Fenwick, Craig; Naninck, Thibaut; Lemaitre, Julien; Gomez-Pacheco, Mario; Kahlaoui, Nidhal; Contreras, Vanessa; Relouzat, Francis; Fang, Raphaël Ho Tsong; Wang, Zhiqing; Ellis, Jerome; Chapon, Catherine; Centlivre, Mireille; Wiedemann, Aurelie; Lacabaratz, Christine; Surenaud, Mathieu; Szurgot, Inga; Liljeström, Peter; Planas, Delphine; Bruel, Timothée; Schwartz, Olivier; Werf, Sylvie van der; Pantaleo, Giuseppe; Prague, Mélanie; Thiébaut, Rodolphe; Zurawski, Gerard; Lévy, Yves; Grand, Roger Le.
Afiliação
  • Marlin R; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Godot V; Vaccine Research Institute, Creteil, France.
  • Cardinaud S; Inserm U955, Créteil, France.
  • Galhaut M; Vaccine Research Institute, Creteil, France.
  • Coleon S; Inserm U955, Créteil, France.
  • Zurawski S; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Dereuddre-Bosquet N; Vaccine Research Institute, Creteil, France.
  • Cavarelli M; Inserm U955, Créteil, France.
  • Gallouët AS; Vaccine Research Institute, Creteil, France.
  • Maisonnasse P; Baylor Scott and White Research Institute and INSERM U955, Dallas, TX, USA.
  • Dupaty L; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Fenwick C; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Naninck T; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Lemaitre J; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Gomez-Pacheco M; Vaccine Research Institute, Creteil, France.
  • Kahlaoui N; Inserm U955, Créteil, France.
  • Contreras V; Service of Immunology and Allergy Lausanne University Hospital, Lausanne, Switzerland.
  • Relouzat F; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Fang RHT; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Wang Z; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Ellis J; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Chapon C; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Centlivre M; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Wiedemann A; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Lacabaratz C; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Surenaud M; Vaccine Research Institute, Creteil, France.
  • Szurgot I; Baylor Scott and White Research Institute and INSERM U955, Dallas, TX, USA.
  • Liljeström P; Vaccine Research Institute, Creteil, France.
  • Planas D; Baylor Scott and White Research Institute and INSERM U955, Dallas, TX, USA.
  • Bruel T; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.
  • Schwartz O; Vaccine Research Institute, Creteil, France.
  • Werf SV; Inserm U955, Créteil, France.
  • Pantaleo G; Vaccine Research Institute, Creteil, France.
  • Prague M; Inserm U955, Créteil, France.
  • Thiébaut R; Vaccine Research Institute, Creteil, France.
  • Zurawski G; Inserm U955, Créteil, France.
  • Lévy Y; Vaccine Research Institute, Creteil, France.
  • Grand RL; Inserm U955, Créteil, France.
Nat Commun ; 12(1): 5215, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34471122
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article